Töyer Şahin Nilhan, Ek Hülya, Pehlivan Seda
Vocational School of Health Services, Istanbul Esenyurt University, İstanbul, Turkey.
Bursa Uludağ University Hospital, Diabetes Training Nurse, Bursa, Turkey.
J Clin Nurs. 2025 Jul;34(7):2840-2851. doi: 10.1111/jocn.17482. Epub 2024 Oct 6.
Diabetes is a global problem. Diabetes nurses, in particular, take great responsibility in reducing and controlling the fears of individuals using insulin and increasing their capacity to tolerate discomfort.
This study was conducted to examine the effects of the capacity to tolerate discomfort on the fear of self-injection and the status of testing blood glucose levels in patients with type 1 and type 2 diabetes using insulin.
This cross-sectional study was conducted between December 2022 and February 2023 with 320 adult patients with type 1 and type 2 diabetes using insulin who were followed up in the Endocrinology and Internal Medicine Clinics of a university hospital in Turkey. The data analysis process included analyses of the frequency, independent-samples t-tests, one-way ANOVA, the Kruskal-Wallis H test, and Pearson's correlation analysis. Data were analysed using the IBM SPSS v27.0 software, considering alpha as 0.05.
The mean total Discomfort Intolerance Scale score of the patients was 22.78 ± 6.74, and the mean Fear of Self-Injecting and self-testing was 21.1 ± 6.7. A negative significant correlation was found between the discomfort intolerance levels of the patients and their levels of fear of self-injection and self-testing (p < 0.05).
Individuals with a higher capacity to tolerate discomfort have lower levels of fear of self-testing and self-injection. Therefore, the fear of self-testing and self-injection in patients using insulin injections may affect diabetes self-management.
Individuals with low tolerance for discomfort should be identified, interventions to increase tolerance in individuals at risk should be planned, and diabetes self-management should be better supported.
The reporting of the results of the study adhered to the STROBE guidelines.
糖尿病是一个全球性问题。尤其是糖尿病专科护士,在减轻和控制使用胰岛素患者的恐惧以及增强他们耐受不适的能力方面肩负重大责任。
本研究旨在探讨1型和2型糖尿病胰岛素治疗患者的不适耐受能力对自我注射恐惧及血糖检测状况的影响。
本横断面研究于2022年12月至2023年2月进行,纳入了320例使用胰岛素的1型和2型糖尿病成年患者,这些患者在土耳其一所大学医院的内分泌科和内科门诊接受随访。数据分析过程包括频率分析、独立样本t检验、单因素方差分析、Kruskal-Wallis H检验和Pearson相关分析。使用IBM SPSS v27.0软件进行数据分析,将α设定为0.05。
患者的不适耐受量表总均分是22.78±6.74,自我注射和自我检测恐惧均分是21.1±6.7。患者的不适耐受水平与自我注射和自我检测恐惧水平之间存在显著负相关(p<0.05)。
不适耐受能力较高的个体自我检测和自我注射恐惧水平较低。因此,胰岛素注射患者的自我检测和自我注射恐惧可能会影响糖尿病自我管理。
应识别出不适耐受能力低的个体,规划提高高危个体耐受能力的干预措施,并更好地支持糖尿病自我管理。
本研究结果的报告遵循STROBE指南。